Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fulvestrant vs Exemestane in Postmenopausal Advanced Breast Cancer (FRIEND)
NCT02646735Phase 2Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Dec 2015
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fulvestrant in breast cancer, sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
fulvestrant
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02646735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02646735.